Reports
Sale
Global Infertility Diagnostics Devices Market Size, Share: By Product Type: Imaging Systems, Ovulation Prediction Kits, Sperm Analysis Systems, Others; By Test Type: Female Infertility Testing, Male Infertility Testing; By Patient Type: Male Patients, Female Patients; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Infertility Diagnostics Devices Market Outlook
The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by increasing prevalence of infertility along with technical advancements across the globe.
Key Takeaways
-
Recently WHO estimated that nearly 17.5% of the adult population which makes around 1 in 6 individuals worldwide experience infertility in their lifetime. This estimation creates a sense of urgent, affordable, and high-quality fertility care for those in need.
- In Feb 2024, Australian researchers found that an ultrasound technique may provide a new way to boost sperm movement in the lab, stating that non-invasive technique can increase human sperm movement in the laboratory by 266%.
- The heightened research activities to develop cutting-edge infertility diagnostic tools among both male and female individuals are projected to augment infertility diagnostics devices market demand.
Infertility is an issue that people are facing worldwide. Currently, 1 in every 6 adults suffers from infertility globally. Some major causes for this condition include, a sedentary lifestyle, tobacco, and alcohol consumption, genetics, and environmental factors, among others. Infertility can be diagnosed by undergoing several procedures that require a range of equipment and tools. It has been predicted that persisting conditions may contribute greatly to the decline in male and female fertility by 2060.
Global Infertility Diagnostics Devices Market Trends and Developments
Rising awareness, advancements in diagnostic equipment, and increasing demand for non-invasive diagnosing procedures for infertility comprise some of the key trends and developments in the market.
| Date | Institution | Event |
| Feb 2024 | Israeli university | The result of a collective effort by the scientists in Israel resulted in the creation of artificial testicles in their lab. This groundbreaking development could play a significant role in assisting men with fertility issues globally. Such developments are expected to boost infertility diagnostics devices market share in the forecast period. |
| Feb 2024 | Monash University | A new project called "EndoSim - A simulator for endometriosis diagnosis training" received funding from the Monash Institute of Medical Engineering (MIME). This project aims to develop an effective treatment for endometriosis, a condition that can cause infertility in women. Currently in its initial stages, the project proposes to build a physical pelvic model that is made from ultrasound-compatible materials and has accurate internal anatomical structures that simulate endometriosis. The model will be used to enable novices to acquire the essential skills required to navigate through the pelvic region using ultrasound scanning and to correctly diagnose endometrial tissues. |
| January 2024 | PherDal | The FDA has approved the PherDal kit for over-the-counter home use by individuals who have been suffering from infertility. This kit offers multiple tools such as semen collection and the delivery of semen to the vaginal canal. It to drive infertility diagnostics devices market growth in coming years. |
| December 2023 | Arva Health | The company launched a home fertility test for women dealing with PCOS and thyroid problems. The solution is believed to track hormones while empowering their fertile health. This product was launched specifically focused on providing convenience and privacy contributing to heightened market demand. |
| Key Trend | Impact |
| Heightened Research Activities | The infertility diagnostics devices market demand is driven by continuous exclusive research efforts by researchers to find solutions for infertility issues among male and female individuals. These researchers are addressing the crucial gap of unmet needs in the treatment of infertility. |
| Rising Awareness about Infertility | An escalating rise in awareness among people about the available treatments for infertility problems is being recorded. The rising awareness about infertility contributes to the destigmatization of the condition leading to an increasing number of diagnoses globally. |
| Growing Preference for Non-Invasive Solutions | Common procedures such as ovulation tracking, blood tests, transvaginal ultrasound, hysterosalpingography (HSG), and scrotal ultrasound among others, makes it easy to assess the presence and the level of infertility in individuals. The market is experiencing increasing preference for these procedures leading to infertility diagnostics devices market growth. |
| Increasing Product Launches | The market is witnessing notable product launches enabling the increased market demand. Products such as at-home infertility testing kits by market players are influencing the market growth, specifically in emerging economies. |
Global Infertility Diagnostics Devices Market Analysis
The market growth can be attributed to the increasing rates of infertility along with rising advancements in diagnostic tools. The increasing shift toward single parenting and same-sex couples wanting to conceive is fuelling the market. The increasing awareness and people coming out of their comfort zones to get diagnosed with infertility issues further boost the market.
Global Infertility Diagnostics Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product Type | Imaging systems (Ultrasounds, MRI Systems, and others), Ovulation Prediction Kits, Sperm Analysis Systems, and Others. |
| Test Type | Female Infertility Testing (Ovarian Reserve Testing, Hormonal Level Testing, Tubal Patency Test, and Others) and Male Infertility Testing (Semen Analysis, DNA Fragmentation and Other Sperm Function Tests) |
| Patient Type | Male Patients, Female Patients |
| End User | Hospitals, Fertility Clinics, Homecare Settings, and Others. |
| Region | North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
By product type, the infertility diagnostics devices market share is divided into imaging systems ultrasounds, ovulation prediction kits, sperm analysis systems, and others. Additionally, imaging systems ultrasounds are segmented into ultrasound, and MRI Systems, among others.
The market is segmented by test types into female infertility testing and male infertility testing. Female testing includes ovarian reserve testing, hormonal level testing, tubal patency testing, and others. Further, male infertility testing is divided into semen analysis, DNA fragmentation, and other sperm function tests.
The patient type segment encompasses both male and female patients. With rising lifestyle changes, male and female individuals experience fertility issues parallelly.
By end users, the infertility diagnostics devices market segmentation constitutes hospitals, fertility clinics, homecare settings, and others. Infertility diagnostic tools are used for several testing and treatment procedures at hospitals, and fertility clinics, among other sites.
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market is driven by technological advancements, and rising awareness among people. However, the level of market development and growth rates may vary from region to region.
Global Infertility Diagnostics Devices Market: Competitive Landscape
The key market players contributing to market growth through strategic mergers and acquisitions initiatives, novel product launches, and continuous research and development efforts are as follows:
| Company | Year Founded | Headquarters | Products/Services |
| CooperSurgical, Inc. | 1990 | Trumbull, CT, U.S.A. | Assisted Reproductive Tech, Contraception, Donor Egg and Sperm, Gynecological Surgery, Labor and Delivery, Newborn Stem Cells, Uterine Health Outpatient Treatments, Wellcare and Diagnostics. |
| Vitrolife | 1994 | Västra Frölunda | Labware, sperm processing, IVF mediaand oil, Oocyte retrieval needles, micromanipulation pipettes, time-lapse systems and evaluation tools, laser and imaging systems, genomics kits, embryo transfer, cryopreservation. |
| Rocket Medical plc | 1964 | Washington, Tyne and Wear | Embryo Transfer Catheters, HSG & Sonography Procedure Packs, and Suction pumps, among others. |
Other key players in the market include ARQUIMEA, Intin Inc., Hamilton Thorne, Medical Electronic Systems, Bioteknika Healthcare Pvt. Ltd., Varay Laborix, Agappe Diagnostic’s Ltd., Atlas Medical GmbH, Advy Chemical Pvt. Ltd, Trajan Scientific and Medical, Getein Biotech, Inc., and Beckman Coulter, Inc., among others.
Global Infertility Diagnostics Devices Market Analysis by Region
North America is the leading regional market, owing to the presence of key players, the advanced healthcare system which is experiencing rapid advancements, and the higher diagnosis rates of infertility testing. Moreover, the rising rates of infertility and research activities in the region are expected to fuel the infertility diagnostics devices market size in the forecast period.
Europe is the following region in the market. The growth can be attributed to the supportive government policies, high public and private healthcare expenditure, and availability of cutting-edge treatments for the condition. Asia Pacific is expected to witness rapid growth in the coming years, owing to increased government initiatives around spreading knowledge around infertility. Rising disposable incomes also fuel the market value in the region.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Test Type |
|
| Breakup by Patient Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Infertility Diagnostics Devices Market Overview
3.1 Global Infertility Diagnostics Devices Market Historical Value (2017-2023)
3.2 Global Infertility Diagnostics Devices Market Forecast Value (2024-2032)
4 Global Infertility Diagnostics Devices Market Landscape*
4.1 Global Infertility Diagnostics Devices Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Infertility Diagnostics Devices Market: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Test Type
4.2.3 Analysis by Patient Type
5 Global Infertility Diagnostics Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Infertility Diagnostics Devices Market Segmentation (2017-2032)
6.1 Global Infertility Diagnostics Devices Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Imaging Systems
6.1.2.1 Ultrasound
6.1.2.2 MRI Systems
6.1.2.3 Others
6.1.3 Ovulation Prediction Kits
6.1.4 Sperm Analysis Systems
6.1.5 Others
6.2 Global Infertility Diagnostics Devices Market (2017-2032) by Test Type
6.2.1 Market Overview
6.2.2 Female Infertility Testing
6.2.2.1 Ovarian Reserve Testing
6.2.2.2 Hormonal Level Testing
6.2.2.3 Tubal Patency Test
6.2.2.4 Others
6.2.3 Male Infertility Testing
6.2.3.1 Semen Analysis
6.2.3.2 DNA Fragmentation
6.2.3.3 Other Sperm Function Tests
6.3 Global Infertility Diagnostics Devices Market (2017-2032) by Patient Type
6.3.1 Market Overview
6.3.2 Male Patients
6.3.3 Female Patients
6.4 Global Infertility Diagnostics Devices Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Fertility Clinics
6.4.4 Homecare Settings
6.4.5 Others
6.5 Global Infertility Diagnostics Devices Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Infertility Diagnostics Devices Market (2017-2032)
7.1 North America Infertility Diagnostics Devices Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Imaging Systems
7.1.2.1 Ultrasound
7.1.2.2 MRI Systems
7.1.2.3 Others
7.1.3 Ovulation Prediction Kits
7.1.4 Sperm Analysis Systems
7.1.5 Others
7.2 North America Infertility Diagnostics Devices Market (2017-2032) by Test Type
7.2.1 Market Overview
7.2.2 Female Infertility Testing
7.2.2.1 Ovarian Reserve Testing
7.2.2.2 Hormonal Level Testing
7.2.2.3 Tubal Patency Test
7.2.2.4 Others
7.2.3 Male Infertility Testing
7.2.3.1 Semen Analysis
7.2.3.2 DNA Fragmentation
7.2.3.3 Other Sperm Function Tests
7.3 North America Infertility Diagnostics Devices Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Infertility Diagnostics Devices Market (2017-2032)
8.1 Europe Infertility Diagnostics Devices Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Imaging Systems
8.1.2.1 Ultrasound
8.1.2.2 MRI Systems
8.1.2.3 Others
8.1.3 Ovulation Prediction Kits
8.1.4 Sperm Analysis Systems
8.1.5 Others
8.2 Europe Infertility Diagnostics Devices Market (2017-2032) by Test Type
8.2.1 Market Overview
8.2.2 Female Infertility Testing
8.2.2.1 Ovarian Reserve Testing
8.2.2.2 Hormonal Level Testing
8.2.2.3 Tubal Patency Test
8.2.2.4 Others
8.2.3 Male Infertility Testing
8.2.3.1 Semen Analysis
8.2.3.2 DNA Fragmentation
8.2.3.3 Other Sperm Function Tests
8.3 Europe Infertility Diagnostics Devices Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Infertility Diagnostics Devices Market (2017-2032)
9.1 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Imaging Systems
9.1.2.1 Ultrasound
9.1.2.2 MRI Systems
9.1.2.3 Others
9.1.3 Ovulation Prediction Kits
9.1.4 Sperm Analysis Systems
9.1.5 Others
9.2 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Test Type
9.2.1 Market Overview
9.2.2 Female Infertility Testing
9.2.2.1 Ovarian Reserve Testing
9.2.2.2 Hormonal Level Testing
9.2.2.3 Tubal Patency Test
9.2.2.4 Others
9.2.3 Male Infertility Testing
9.2.3.1 Semen Analysis
9.2.3.2 DNA Fragmentation
9.2.3.3 Other Sperm Function Tests
9.3 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Infertility Diagnostics Devices Market (2017-2032)
10.1 Latin America Infertility Diagnostics Devices Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Imaging Systems
10.1.2.1 Ultrasound
10.1.2.2 MRI Systems
10.1.2.3 Others
10.1.3 Ovulation Prediction Kits
10.1.4 Sperm Analysis Systems
10.1.5 Others
10.2 Latin America Infertility Diagnostics Devices Market (2017-2032) by Test Type
10.2.1 Market Overview
10.2.2 Female Infertility Testing
10.2.2.1 Ovarian Reserve Testing
10.2.2.2 Hormonal Level Testing
10.2.2.3 Tubal Patency Test
10.2.2.4 Others
10.2.3 Male Infertility Testing
10.2.3.1 Semen Analysis
10.2.3.2 DNA Fragmentation
10.2.3.3 Other Sperm Function Tests
10.3 Latin America Infertility Diagnostics Devices Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Infertility Diagnostics Devices Market (2017-2032)
11.1 Middle East and Africa Infertility Diagnostics Devices Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Imaging Systems
11.1.2.1 Ultrasound
11.1.2.2 MRI Systems
11.1.2.3 Others
11.1.3 Ovulation Prediction Kits
11.1.4 Sperm Analysis Systems
11.1.5 Others
11.2 Middle East and Africa Infertility Diagnostics Devices Market (2017-2032) by Test Type
11.2.1 Market Overview
11.2.2 Female Infertility Testing
11.2.2.1 Ovarian Reserve Testing
11.2.2.2 Hormonal Level Testing
11.2.2.3 Tubal Patency Test
11.2.2.4 Others
11.2.3 Male Infertility Testing
11.2.3.1 Semen Analysis
11.2.3.2 DNA Fragmentation
11.2.3.3 Other Sperm Function Tests
11.3 Middle East and Africa Infertility Diagnostics Devices Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 CooperSurgical, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Vitrolife
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 ARQUIMEA
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Intin Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hamilton Thorne
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Rocket Medical plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medical Electronic Systems
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bioteknika Healthcare Pvt. Ltd
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Varay Laborix
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Agappe Diagnostic’s Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Atlas Medical GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Advy Chemical Pvt. Ltd
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Trajan Scientific and Medical.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Getein Biotech, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Beckman Coulter, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Infertility Diagnostics Devices Market– Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by the increasing rates of infertility across the globe.
The market demand is driven by heightened awareness about available treatments for infertility among people along with rising disposable income.
The market growth is influenced by increasing technical advancements, research activities, government investments, and destigmatization of infertility.
Product types include imaging systems ultrasounds, ovulation prediction kits, sperm analysis systems, and others. Imaging systems are further divided into, ultrasound, and MRI systems, among others.
Test types include female infertility testing and male infertility testing. Female infertility testing is further bifurcated into ovarian reserve testing, hormonal level testing, tubal patency testing, and others. Male infertility testing is further segmented into semen analysis, DNA fragmentation, and other sperm function tests.
The market includes both male and female patients.
End users in the market include hospitals, fertility clinics, homecare settings, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are CooperSurgical, Inc., Vitrolife, ARQUIMEA, Intin Inc., Rocket Medical plc, Medical Electronic Systems, Bioteknika Healthcare Pvt. Ltd, Varay Laborix, Agappe Diagnostic’s Ltd, Atlas Medical GmbH, Advy Chemical Pvt. Ltd, Trajan Scientific and Medical., Getein Biotech, Inc., Beckman Coulter, Inc., Hamilton Thorne.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER